Growth and Funding Recent Series B expansion and a $6 million financing round, including $3.5 million in new funding, indicate strong investor confidence and growing capacity to scale sales efforts and expand hospital deployments.

Innovation Edge FDA 51(k) cleared Soteria bed barrier and neonatal mattress barrier position Trinity Guardion with a unique, defensible product differentiator in hospital bed hygiene, creating compelling value propositions for infection control budgets.

Operational Savings Evidence of labor savings and extended bed asset life from the Soteria system suggests a compelling payback story for purchasing committees aiming to reduce turnover, reprocessing time, and mattress wear.

Healthcare Partnerships Technology Breakthrough Designation and Premier recognition strengthen credibility with hospital networks and GPOs, enabling targeted outreach to infection prevention, facilities, and procurement leaders.

Expansion Opportunities Recent Neonatal Mattress Barrier launch opens cross-sell potential into neonatal and high-acuity units, with opportunities to upsell comprehensive barrier systems across additional patient care environments.